Oncology & Cancer

Team identifies the cells responsible for colon cancer relapse

Colon cancer is the third most common cancer in the world, with about 2 million new cases each year. Most patients are diagnosed when the tumor is still located in the colon or rectum. These tumors are removed by surgery, ...

Oncology & Cancer

A stem cell protein facilitates relapse of pediatric brain tumors

Medulloblastoma is the most common form of malignant brain tumor in children, which often can be cured with operation, radiation and chemotherapy. But a distinct type of medulloblastoma has an increased risk of becoming resistant ...

Oncology & Cancer

Promising approach to mitigate complications of leukemia treatment

Researchers at Baylor College of Medicine and collaborating institutions have engineered immune cells to control two major life-threatening complications, namely graft-vs-host disease (GvHD) and cancer relapse, which typically ...

Oncology & Cancer

Study finds 10-second videos can predict blood cancer relapse

In a new study from Vanderbilt University Medical Center, 10-second videos of white blood cell motion in the skin's microvasculature greatly improved the prediction of which stem cell and bone marrow transplant patients would ...

Oncology & Cancer

New lung cancer trial to help predict relapse

A new international Phase 3 clinical trial coordinated by Crick Senior Group Leader and Cancer Research UK's chief clinician, Charles Swanton, will use personalised detection tests to look for the earliest signs of relapse ...

page 1 from 8